Common recognition principles of B-cell receptor immunoglobulins in CLL and autoimmune disorders

被引:0
|
作者
Binder, M. [1 ]
Seismann, H. [1 ]
Wehr, C. [2 ]
Ummanni, R. [3 ]
Balabanov, S. [1 ]
Trepel, M. [1 ]
机构
[1] Uniklin Hamburg Eppendorf, Hamburg, Germany
[2] Uniklin Freiburg, Freiburg, Germany
[3] DKFZ, Heidelbert, Germany
来源
ONKOLOGIE | 2011年 / 34卷
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:195 / 195
页数:1
相关论文
共 50 条
  • [21] GENETIC PREDISPOSITION OF AUTOIMMUNE-DISEASE AND B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL)
    SHIRAI, T
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 173 (01): : 133 - 140
  • [22] Premonoclonal B-cell lymphocytosis: the CLL cell of origin
    Marti, Gerald
    BLOOD, 2022, 139 (10) : 1436 - 1437
  • [23] B Cell Receptor and Antigens in CLL
    Agathangelidis, Andreas
    Ntoufa, Stavroula
    Stamatopoulos, Kostas
    ADVANCES IN CHRONIC LYMPHOCYTIC LEUKEMIA, 2013, 792 : 1 - 24
  • [24] Inhibiting recognition of the B-cell receptor by the tyrosine kinase Syk
    Horton, Timothy M.
    Visperas, Patrick R.
    Kuriyan, John
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [25] CHARACTERIZATION OF THE DNA-DAMAGE RESPONSE DOWNSTREAM OF B-CELL RECEPTOR SIGNALING IN CLL
    Nickel, N.
    Roth, A.
    Pallasch, C. P.
    HAEMATOLOGICA, 2015, 100 : 413 - 413
  • [26] Subepidermal autoimmune bullous skin diseases associated with B-cell lymphoproliferative disorders
    Aractingi, S
    Bachmeyer, C
    Prost, C
    Caux, F
    Flageul, B
    Fermand, JP
    MEDICINE, 1999, 78 (04) : 228 - 235
  • [27] Overexpression of TOSO in CLL is triggered by B-cell receptor signaling and associated with progressive disease
    Pallasch, Christian Philipp
    Schulz, Alexandra
    Kutsch, Nadine
    Schwamb, Janine
    Hagist, Susanne
    Kashkar, Hamid
    Ultsch, Alfred
    Wickenhauser, Claudia
    Hallek, Michael
    Wendtner, Clemens-Martin
    BLOOD, 2008, 112 (10) : 4213 - 4219
  • [28] Overexpression of TOSO in CLL Is Triggered by B-Cell Receptor Signaling and Associated with Progressive Disease
    Pallasch, Christian P.
    Schulz, Alexandra
    Kutsch, Nadine
    Schwamb, Janine
    Hagist, Susanne
    Wickenhauser, Claudia
    Ultsch, Alfred
    Kashkar, Humid
    Hallek, Michael
    Wendtner, Clemens-Martin
    BLOOD, 2008, 112 (11) : 721 - 721
  • [29] Ibrutinib as a treatment of hematologic autoimmune disorders in patients with indolent B-cell lymphoma
    Daniel, Adrien
    Ghez, David
    Ravaiau, Camille
    Cavalieri, Doriane
    Tournilhac, Olivier
    Herbaux, Charles
    Roriz, Melanie
    Wemeau, Mathieu
    Guillet, Stephanie
    Bossard, Jean Baptiste
    Helene, Demarquette
    Kaphan, Eleonore
    Caroline, Regny
    Florence, Lachenal
    Pierache, Adeline
    Michel, Marc
    Godeau, Bertrand
    Terriou, Louis
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2022, 109 (06) : 719 - 727
  • [30] Identification in CLL of circulating intraclonal subgroups with varying B-cell receptor expression and function
    Coelho, Vania
    Krysov, Sergey
    Steele, Andrew
    Sanchez Hidalgo, Marina
    Johnson, Peter W.
    Chana, Prabhjoat S.
    Packham, Graham
    Stevenson, Freda K.
    Forconi, Francesco
    BLOOD, 2013, 122 (15) : 2664 - 2672